ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

robot
Abstract generation in progress

The Schall Law Firm has announced a class action lawsuit against Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) for alleged securities fraud between November 3, 2023, and March 16, 2026. Investors who purchased Aldeyra securities during this period and suffered losses are encouraged to contact the firm to discuss their rights and potentially lead the lawsuit. The complaint asserts that Aldeyra made false and misleading statements regarding inconsistencies in clinical trials for its reproxalap drug candidate, causing investor damages.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin